Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect of Hydromorphone Hydrochloride Epidural Preemptive Analgesia on Postoperative Pain After Cesarean Section

NCT06823180 is registered in ClinicalTrials.gov with Liquan Liang as lead sponsor.

NCT NCT06823180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect of Hydromorphone Hydrochloride Epidural Preemptive Analgesia on Postoperative Pain After Cesarean Section
Lead sponsor
Liquan Liang
Phase
Phase 4
Overall status
Completed
Start date
March 3, 2025
Completion date
August 28, 2025
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-surgical pain